4.7 Article

Effects of Sodium-Glucose Transporter 2 Inhibitors (SGLT2-I) in Patients With Ischemic Heart Disease (IHD) Treated by Coronary Artery Bypass Grafting via MiECC: Inflammatory Burden, and Clinical Outcomes at 5 Years of Follow-Up

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Cardiac & Cardiovascular Systems

Hyperglycemia, inflammatory response and infarct size in obstructive acute myocardial infarction and MINOCA

Pasquale Paolisso et al.

Summary: The study confirmed the association of hyperglycemic obs-AMI with elevated inflammatory markers and larger infarct sizes. MINOCA patients showed modest myocardial damage, regardless of admission glucose levels.

CARDIOVASCULAR DIABETOLOGY (2021)

Article Endocrinology & Metabolism

Sodium-glucose co-transporter2 expression and inflammatory activity in diabetic atherosclerotic plaques: Effects of sodium-glucose co-transporter2 inhibitor treatment

Nunzia D'Onofrio et al.

Summary: The study demonstrated that SGLT2 inhibitors have a positive regulatory effect on atherosclerotic plaques in diabetic patients, showing significant improvements in inflammation and oxidative stress. Patients without diabetes had significantly higher overall survival from MACE at 2-year follow-up, while diabetic patients using SGLT2 inhibitors had a significantly lower rate of MACE over 2 years compared to non-users.

MOLECULAR METABOLISM (2021)

Article Cardiac & Cardiovascular Systems

Microvascular Dysfunction in Patients With Type II Diabetes Mellitus: Invasive Assessment of Absolute Coronary Blood Flow and Microvascular Resistance Reserve

Emanuele Gallinoro et al.

Summary: This study compared coronary flow, resistance, coronary flow reserve, and microvascular resistance reserve between diabetic and non-diabetic patients using continuous intracoronary thermodilution. The findings showed that diabetic patients had significantly lower CFR and MRR compared to non-diabetic patients, while resting and hyperemic coronary flow and resistance were similar between the two groups.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)

Article Biochemistry & Molecular Biology

Metformin Therapy Effects on the Expression of Sodium-Glucose Cotransporter 2, Leptin, and SIRT6 Levels in Pericoronary Fat Excised from Pre-Diabetic Patients with Acute Myocardial Infarction

Celestino Sardu et al.

Summary: The study found that PDM patients had higher levels of inflammation in pericoronary fat, while metformin therapy could potentially reduce inflammatory parameters, SGLT2, and leptin levels, and improve SIRT6 levels.

BIOMEDICINES (2021)

Article Cardiac & Cardiovascular Systems

2018 ESC/EACTS Guidelines on myocardial revascularization

Franz-Josef Neumann et al.

EUROPEAN HEART JOURNAL (2019)

Article Cardiac & Cardiovascular Systems

SGLT2 Inhibitor, Canagliflozin, Attenuates Myocardial Infarction in the Diabetic and Nondiabetic Heart

Ven G. Lim et al.

JACC-BASIC TO TRANSLATIONAL SCIENCE (2019)

Article Cardiac & Cardiovascular Systems

Minimized extracorporeal circulation system in coronary artery bypass surgery: a 10-year single-center experience with 2243 patients

Thomas Puehler et al.

EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2011)